✦ LIBER ✦

Phase II study of carboplatin and whole body hyperthermia (WBH) in recurrent and metastatic cervical cancer

✍ Scribed by O. Richel; P.J. Zum Vörde Sive Vörding; R. Rietbroek; J. Vander Velden; J.D.P. Van Dijk; M.S. Schilthuis; A.M. Westermann

Book ID: 113959533
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 185 KB
Volume: 95
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2004.08.023

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Whole-body hyperthermia (WBH) in combina

Whole-body hyperthermia (WBH) in combination with carboplatin in patients with recurrent ovarian cancer — A phase II study

✍ Akin Atmaca; Salah-Eddin Al-Batran; Antje Neumann; Yvonne Kolassa; Dirk Jäger; A 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 168 KB

Efficacy and toxicity of chemotherapy (c

Efficacy and toxicity of chemotherapy (carboplatin/ifosfamide) combined with whole body hyperthermia (WBH) in patients with recurrent ovarian cancer — a phase II study (dolphin-1-study)

✍ Strobl, B.; Janni, W.; Rjosk, D.; Bergauer, F.; Kornya, L.; Sommer, H. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 170 KB

A pilot study of whole body hyperthermia

A pilot study of whole body hyperthermia and carboplatin in platinum-resistant ovarian cancer

✍ A.M Westermann; E.A Grosen; D.M Katschinski; D Jäger; R Rietbroek; J.C Schink; C 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 126 KB

A phase I study of ifosfamide, paclitaxe

A phase I study of ifosfamide, paclitaxel, and carboplatin in advanced and recurrent cervical cancer

✍ Levi S. Downs Jr.; Patricia L. Judson; Peter A. Argenta; Linda F. Carson; Matthe 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 97 KB

Phase II trial of carboplatin and etopos

Phase II trial of carboplatin and etoposide in metastatic breast cancer

✍ John Crown; Thomas Hakes; Bonnie Reichman; David Lebwohl; Theresa Gilewski; Anto 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 345 KB 👁 2 views

## Background: High-dose chemotherapy with hematopoietic support produces high rates of response in metastatic breast cancer. to facilitate new high-dose regimens there is a need to identify active agents with toxicity limited to hematopoietic suppression. cisplatin/etoposide is a highly active reg

Phase II clinical study of irinotecan an

Phase II clinical study of irinotecan and cisplatin as first-line chemotherapy in metastatic or recurrent cervical cancer

✍ Imjai Chitapanarux; Anun Tonusin; Vimol Sukthomya; Chamita Charuchinda; Nantaka 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 87 KB